{
    "id": 22763,
    "fullName": "CBL dec exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "CBL dec exp indicates decreased expression of the Cbl protein. However, the mechanism causing the decreased expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 867,
        "geneSymbol": "CBL",
        "terms": [
            "CBL",
            "C-CBL",
            "CBL2",
            "FRA11B",
            "NSLL",
            "RNF55"
        ]
    },
    "variant": "dec exp",
    "createDate": "05/18/2016",
    "updateDate": "07/30/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 6423,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Emerging",
            "efficacyEvidence": "In a preclinical study, addition of Tarceva (erlotinib) overcame Gemzar (gemcitabine)-resistance in pancreatic ductal carcinoma cell lines with reduced Cbl expression via shRNA, resulted in decreased viability in cell culture and reduced tumor growth in cell line xenograft models (PMID: 25348515).",
            "molecularProfile": {
                "id": 23382,
                "profileName": "CBL dec exp"
            },
            "therapy": {
                "id": 2381,
                "therapyName": "Erlotinib + Gemcitabine",
                "synonyms": null
            },
            "indication": {
                "id": 3587,
                "name": "pancreatic ductal carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 5579,
                    "pubMedId": 25348515,
                    "title": "Low expression of the E3 ubiquitin ligase CBL confers chemoresistance in human pancreatic cancer and is targeted by epidermal growth factor receptor inhibition.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25348515"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        }
    ],
    "molecularProfiles": [
        {
            "id": 23382,
            "profileName": "CBL dec exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}